Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    AGN

No quotes available
-- USD   0.00%
05:43a ALLERGAN : Gets CHMP Positive Opinion For Truberzi To Treat IBS-D In..
07/23 ADAMIS PHARMACE : Provides Update On License Agreement with Allergan..
07/20 Allergan and Adamas Announce New Expanded Indication for NAMZARIC..
 SummaryQuotesNewsCalendarCompanyFinancials 
Company
Allergan, Inc. operates as a global healthcare company.It engages in the developing and commercializing innovative specialty pharmaceutical, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity... 
Sector
Pharmaceuticals
Calendar
10/25Earnings Release
More about the company
Latest news on ALLERGAN, INC.
05:43a ALLERGAN : Gets CHMP Positive Opinion For Truberzi To Treat IBS-D In Adults
07/23 ADAMIS PHARMACEUTICALS : Provides Update On License Agreement with Allergan plc
07/20 Allergan and Adamas Announce New Expanded Indication for NAMZARIC (Memantine ..
07/20 ALLERGAN : Some of the most inventive medicines, devices, and procedures in the ..
07/20 ALLERGAN : FDA approves expanded label for Namzaric in Alzheimer’s disease
07/20 ALLERGAN : Assigned Patent
07/19 SoftBank bid for ARM catches some hedge funds off guard
07/18 ALLERGAN : Analysts cut Teva price targets
07/17 ALLERGAN : Teva Pharmaceutical Industries Ltd. $40B Deal With Allergan Plc , To ..
07/15 ALLERGAN : Teva readies for Allergan deal with bond sale
More news
Sector news : Pharmaceuticals - NEC
07/25DJGilead Sales of Hepatitis C Drugs Fall 19%
07/25DJSTADA ARZNEIMITTEL : Feels More Heat From Active Ownership
07/25DJASTRAZENECA : 2Q 2016 -- Forecast
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
2015 MANNKIND : A Head Pain Gain Or A Pocket-Book Drain?
2015 Tracking Dan Loeb's Third Point Portfolio - Q1 2015 Update
2015 Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2015 Update
2015 Time Warner Is A Buy - Cramer's Lightning Round (5/21/15)
2015 Tracking John Paulson's Paulson & Company Portfolio - Q1 2015 Update
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
Ambrose Robert Douglas Bailey Chairman & President
Scott M. Whitcup Chief Scientific Officer & Executive VP-Research
Raymond H. Diradoorian Executive VP-Global Technical Operations
Maria Teresa Hilado Director
Joann Bradley Investor Relations Contact
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN, INC.13.00%0
JOHNSON & JOHNSON21.58%343 528
PFIZER INC.13.94%223 065
NOVARTIS AG-5.13%218 815
ROCHE HOLDING LTD.-9.62%217 668
MERCK & CO., INC.10.87%162 096
More Results